Alzheimer’s Drug Discovery Foundation -The Treat Frontotemporal dementia (FTD) Fund



Topic: Alzheimer.

Destination: The fund aims to de-risk clinical programs by supporting clinical trials with clear go/no-go criteria and if positive, sufficient data to encourage follow on funding of the approach. Programs will be considered that test novel or repurposed drug candidates or devices in phase 1 or phase 2 clinical trials for FTD disorders, led by academic researchers or biotechnology companies. Both disease-modifying and symptomatic approaches will be accepted.

Budget: Up to $2,000,000 based on stage and scope of the trial.

Duration: Not indicated.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: